Compounds > amonafide
Page last updated: 2024-08-23

amonafide and Carcinoma, Squamous Cell

amonafide has been researched along with Carcinoma, Squamous Cell in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asbury, RF; Blessing, JA; Soper, JT1
Conrad, ME; Eisenberg, P; Fisher, RI; Fleming, T; MacDonald, JS; Poplin, E1
Benson, AB; Blough, R; French, S; Kies, M; Kilton, LJ; Lad, T; Mullane, M; Rosen, F; Vokes, EE; Wade, J1
Adams, GL; Dutcher, JP; Leaf, AN; Neuberg, D; Ritch, PS; Schwartz, EL; Wadler, S1
Alberts, DS; Craig, JB; Hannigan, EV; Liu, PY; Malviya, VK; Surwit, EA1

Trials

5 trial(s) available for amonafide and Carcinoma, Squamous Cell

ArticleYear
A Gynecologic Oncology Group phase II study of amonafide (NSC #308847) in squamous cell carcinoma of the cervix.
    American journal of clinical oncology, 1994, Volume: 17, Issue:2

    Topics: Adenine; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Organophosphonates; Pelvic Neoplasms; Treatment Outcome; Uterine Cervical Neoplasms

1994
Amonafide treatment of refractory esophageal cancer. A Southwest Oncology Group study.
    Investigational new drugs, 1993, Volume: 11, Issue:1

    Topics: Adenine; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drugs, Investigational; Esophageal Neoplasms; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates; Prognosis

1993
Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study.
    Investigational new drugs, 1995, Volume: 13, Issue:3

    Topics: Adenine; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates; Treatment Outcome

1995
An ECOG phase II study of amonafide in unresectable or recurrent carcinoma of the head and neck (PB390). Eastern Cooperative Oncology Group.
    Investigational new drugs, 1997, Volume: 15, Issue:2

    Topics: Adenine; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates

1997
Evaluation of amonafide in cervical cancer, phase II. A SWOG study.
    American journal of clinical oncology, 1992, Volume: 15, Issue:1

    Topics: Adenine; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Neoplasm Recurrence, Local; Organophosphonates; Survival Analysis; Uterine Cervical Neoplasms

1992